255 related articles for article (PubMed ID: 31707785)
1. Characterization of carbapenem-resistant but cephalosporin-susceptible
Khalili Y; Yekani M; Goli HR; Memar MY
Acta Microbiol Immunol Hung; 2019 Dec; 66(4):529-540. PubMed ID: 31707785
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
3. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
4. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
5. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
Zeng ZR; Wang WP; Huang M; Shi LN; Wang Y; Shao HF
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
[TBL] [Abstract][Full Text] [Related]
7. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
8. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
9. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
10. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
Yi MY; Wang PY; Huang HJ; Liu YC
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):457-62. PubMed ID: 16677571
[TBL] [Abstract][Full Text] [Related]
11. Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.
Castanheira M; Mills JC; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2014 Nov; 58(11):6844-50. PubMed ID: 25182652
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology and carbapenem resistance of
Khalili Y; Memar MY; Farajnia S; Adibkia K; Kafil HS; Ghotaslou R
J Wound Care; 2021 Feb; 30(2):135-141. PubMed ID: 33573489
[TBL] [Abstract][Full Text] [Related]
14. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
[TBL] [Abstract][Full Text] [Related]
15. Association of carbapenem and multidrug resistance with the expression of efflux pump-encoding genes in Pseudomonas aeruginosa clinical isolates.
Yousefi S; Nazari M; Ramazanzadeh R; Sahebkar A; Safarzadeh E; Khademi F
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):161-166. PubMed ID: 37227802
[TBL] [Abstract][Full Text] [Related]
16. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
19. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
